Related Experiment Video
Updated: Jul 25, 2026
07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Suicidality in clinical practice: anxieties and answers
1Department of Psychology & Neuroscience, Baylor University, TX 97334, USA. M_Rud@baylor.edu
Journal of Clinical Psychology
|December 13, 2005
Summary
This special issue addresses clinical suicidality, covering risk assessment, management, and psychotherapy for suicidal individuals. It offers practical recommendations for clinicians, focusing on recent advances in understanding and treating suicide risk.
Area of Science:
- Clinical Psychology
- Psychiatry
- Mental Health
Background:
- Suicidality presents complex challenges in clinical practice.
- Recent advances in clinical suicidology offer new insights.
- Effective risk management and psychotherapy are crucial for suicidal individuals.
Purpose of the Study:
- To provide a comprehensive overview of suicidality in clinical practice.
- To summarize recent advances and challenges in clinical suicidology.
- To offer practical clinical recommendations for managing suicide risk.
Main Methods:
- Review of current literature and clinical practices in suicidology.
- Inclusion of case vignettes to illustrate clinical scenarios.
- Focus on evidence-based recommendations for practitioners.
Main Results:
- Coverage of risk assessment, risk management, and psychotherapy for suicidal patients.
- Discussion of specific interventions like no-suicide contracts.
- Exploration of the risk of suicide associated with selective serotonin reuptake inhibitors (SSRIs) in children and adolescents.
Conclusions:
- The articles provide clear and important clinical implications for practitioners.
- Enhanced understanding and management of suicidality are achievable.
- This issue serves as a valuable resource for clinicians dealing with suicidal patients.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Related Concept Videos
01:18Anxiety: Overview
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:30Stress and Mental Health
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...